HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vijay Dhawan Selected Research

4- phenyl- 5,5- dicarbethoxy- 2- pyrrolidinone

3/2021Dynamic 18F-FPCIT PET: Quantification of Parkinson's disease metabolic networks and nigrostriatal dopaminergic dysfunction in a single imaging session.
11/2016Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
9/2015Abnormal metabolic pattern associated with cognitive impairment in Parkinson's disease: a validation study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vijay Dhawan Research Topics

Disease

29Parkinson Disease (Parkinson's Disease)
06/2022 - 08/2002
6Parkinsonian Disorders (Parkinsonism)
03/2013 - 11/2002
5Dyskinesias (Dyskinesia)
06/2021 - 11/2002
4Neurodegenerative Diseases (Neurodegenerative Disease)
03/2022 - 12/2007
3Alzheimer Disease (Alzheimer's Disease)
11/2016 - 02/2009
3Cognitive Dysfunction
09/2015 - 08/2009
3Dementia (Dementias)
04/2014 - 08/2009
3Multiple System Atrophy
03/2013 - 07/2005
2Corticobasal Degeneration
03/2013 - 07/2005
2Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
03/2013 - 07/2005
2Tremor (Tremors)
01/2011 - 02/2004
1Frontotemporal Dementia (Semantic Dementia)
01/2018
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2015
1Traumatic Brain Injuries (Traumatic Brain Injury)
06/2015
1Brain Diseases (Brain Disorder)
08/2014
1Disease Progression
08/2014
1Type 2 Diabetes Mellitus (MODY)
04/2014
1Huntington Disease (Huntington's Disease)
09/2013
1Mental Disorders (Mental Disorder)
11/2012
1Neurobehavioral Manifestations
10/2011
1Gaucher Disease (Gaucher's Disease)
07/2010
1Atrophy
08/2009
1Mood Disorders (Mood Disorder)
08/2009
1Marijuana Abuse (Cannabis Abuse)
05/2008
1Edema (Dropsy)
04/2006
1Dystonia (Limb Dystonia)
07/2003
1Dystonia musculorum deformans type 1
07/2003

Drug/Important Bio-Agent (IBA)

8Glucose (Dextrose)FDA LinkGeneric
04/2014 - 07/2003
6Biomarkers (Surrogate Marker)IBA
03/2022 - 12/2007
6Levodopa (L Dopa)FDA LinkGeneric
06/2021 - 10/2006
5Dopamine (Intropin)FDA LinkGeneric
10/2013 - 11/2002
34- phenyl- 5,5- dicarbethoxy- 2- pyrrolidinoneIBA
03/2021 - 09/2015
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2021 - 05/2017
2Serotonin (5 Hydroxytryptamine)IBA
11/2012 - 08/2009
2fluorodopa F 18IBA
01/2012 - 03/2006
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
03/2006 - 03/2006
1Pharmaceutical PreparationsIBA
06/2022
1Phenylalanine (L-Phenylalanine)FDA Link
06/2022
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
06/2015
1salicylhydroxamic acid (SHAM)IBA
08/2014
1Antidepressive Agents (Antidepressants)IBA
10/2011
1thymidine 3',5'-diphosphate (pdTp)IBA
01/2011
1Glucosylceramidase (Glucocerebrosidase)IBA
07/2010
1CitalopramFDA LinkGeneric
02/2009
1Galantamine (Galanthamine)FDA LinkGeneric
02/2009
1Cholinergic Agents (Cholinergics)IBA
02/2009
1RacloprideIBA
05/2008
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2006
1Naproxen (Naprosyn)FDA LinkGeneric
04/2006
1CarrageenanIBA
04/2006
1Cholinesterase Inhibitors (Anticholinesterases)IBA
04/2006

Therapy/Procedure

8Therapeutics
01/2018 - 10/2006
7Deep Brain Stimulation
01/2021 - 08/2002
2Transplantation
01/2011 - 11/2002
2Cell Transplantation
01/2011 - 11/2002
1Drug Therapy (Chemotherapy)
01/2016
1Electrodes (Electrode)
06/2009
1Investigational Therapies (Experimental Therapy)
12/2007